Tag: FDA guidance

Bioequivalence of Combination Products: Special Testing Challenges

Posted by: Alan Burity Vitulo in: Health and Medicine

13 Mar | 11:46 AM | 0

Bioequivalence testing for combination products like FDCs, inhalers, and topical creams is far more complex than for single-drug generics. Regulatory, technical, and financial hurdles delay affordable access to life-saving medications.

Physician Liability: Legal Risks of Prescribing Generic Medications

Physicians prescribing generic medications now face rising legal liability as federal rulings shield drug manufacturers from lawsuits. Learn how to protect yourself with proper documentation and prescribing practices.

Nasal Congestion Caused by Medications: How to Break the Cycle and Find Relief

Nasal congestion from overused decongestant sprays is common and reversible. Learn how rebound congestion works, why stopping the spray is the only cure, and what actually helps you recover - backed by clinical evidence.

The Difference Between Medication Side Effects and Adverse Drug Reactions

Learn the critical difference between medication side effects and adverse drug reactions - why confusing them can lead to unnecessary panic, wrong decisions, and even dangerous health outcomes. Clear, science-backed explanation for patients and caregivers.

Seized Counterfeit Medications: Real Cases and What We've Learned

Counterfeit medications are a growing global threat, with millions of fake pills and injections seized each year. Real cases from 2025 reveal how dangerous these fakes are-and what we must do to stop them.

Tag: FDA guidance

Bioequivalence of Combination Products: Special Testing Challenges

recent posts

categories

archives

tags